Please wait...


Generic Name: dabigatran (da BIG a tran)
Brand Names: Pradaxa
Pradaxa (dabigatran) is used to prevent stroke and blood clots in patients with atrial fibrillation. Includes Pradaxa side effects, interactions and indications.
  • Prescription Settings

Prices and coupons of Pradaxa

Current Location: 20149 (Ashburn)
Change Location?

Enter your zip code

Please wait while the prices are loaded...

Don’t see your pharmacy listed? Most pharmacies accept our discounts, so have your pharmacist enter this coupon to see if you will save money:

Drug Information:
Pradaxa (dabigatran) is an anticoagulant (thrombin inhibitor) that helps prevent the formation of blood clots. Pradaxa is used to lower the risk of stroke caused by a blood clot in people with a heart rhythm disorder called atrial fibrillation. This medicine is used when the atrial fibrillation is not caused by a heart valve problem. Pradaxa is also used after hip replacement surgery to prevent a type of blood clot called deep vein thrombosis (DVT), which can lead to blood clots in the lungs (pulmonary embolism). Learn more

Pradaxa Side Effects

Pradaxa Side Effects

Note: This document contains side effect information about dabigatran. Some of the dosage forms listed on this page may not apply to the brand name Pradaxa.

For the Consumer

Applies to dabigatran: oral capsule


Oral route (Capsule)

Premature discontinuation of dabigatran etexilate mesylate increases the risk of thrombotic events. If anticoagulation with dabigatran etexilate mesylate must be discontinued for other than pathological bleeding, consider another anticoagulant. Epidural or spinal hematomas may occur with dabigatran etexilate mesylate therapy in patients undergoing neuraxial anesthesia or spinal puncture. Monitor patients for neurological impairment and treat urgently.

Along with its needed effects, dabigatran (the active ingredient contained in Pradaxa) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking dabigatran:

More common

  • Acid or sour stomach
  • belching
  • black, tarry stools
  • bloody stools
  • constipation
  • diarrhea
  • heartburn
  • indigestion
  • nausea
  • pain or burning in the throat
  • stomach discomfort, upset, burning, or pain
  • vomiting
  • vomiting of blood or material that looks like coffee grounds


  • Cough
  • difficulty with swallowing
  • dizziness
  • fainting or loss of consciousness
  • fast or irregular breathing
  • puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue
  • redness of the skin
  • skin rash, hives, welts, or itching skin
  • tightness in the chest
  • trouble breathing
  • unusual tiredness or weakness

Incidence not known

  • Large, hive-like swelling on the face, eyelids, lips, tongue, throat, hands, legs, feet, or sex organs

For Healthcare Professionals

Applies to dabigatran: oral capsule


Bleeding is the most serious side effect reported with dabigatran (the active ingredient contained in Pradaxa) Major or severe bleeding may occur and, regardless of location, may lead to disabling, life-threatening or even fatal outcomes.


Major bleeds have occurred in critical areas or organs such as, intraocular, intracranial, intraspinal or intramuscular with compartment syndrome, retroperitoneal, intra-articular, or pericardial.

Very common (10% or more): Bleeding up to 16.5%

Uncommon (0.1% to 1%): Hematoma, hemorrhage


Very common (10% or more): Dyspepsia: upper abdominal pain, abdominal discomfort, epigastric discomfort; gastritis like symptoms, esophagitis, erosive gastritis, gastric hemorrhage, hemorrhagic gastritis, hemorrhagic erosive gastritis, and gastrointestinal ulcer

Common (1% to 10%): Diarrhea, nausea

Uncommon (0.1% to 1%): rectal hemorrhage, hemorrhoidal hemorrhage, vomiting, dysphagia

Postmarketing reports: Esophageal ulcer


Common (1% to 10%): Skin hemorrhage

Postmarketing reports: Angioedema


Common (1% to 10%): Anemia

Uncommon (0.1% to 1%): Hemoglobin decreased, thrombocytopenia, occult blood positive

Rare (less than 0.1%): Hematocrit decreased

Postmarketing reports: Thrombocytopenia


Common (1% to 10%): Wound secretion (5%)

Rare (less than 0.1%): Traumatic hemorrhage


Common (1% to 10%): Urogenital hemorrhage (including hematuria 1.2%)

Uncommon (0.1% to 1%): Positive blood urine tests


Common (1% to 10%): Epitaxis (0.6% to 0.7%)

Uncommon (0.1% to 1%): Hemoptysis


Uncommon (0.1% to 1%): Abnormal hepatic function/liver function test, ALT increased, AST increased, hepatic enzyme increased

Rare (less than 0.1%): Hyperbilirubinemia, transaminases increased


Uncommon (0.1% to 1%): Urticaria, rash, pruritus, allergic edema, anaphylactic reaction, anaphylactic shock

Frequency not reported: Bronchospasm


Uncommon (0.1% to 1%): Hemarthrosis

Nervous system

Uncommon (0.1% to 1%): Intracranial hemorrhage

Frequency not reported: Intracerebral hemorrhage (Hemorrhagic stroke), subarachnoid and subdural bleeds


Rare (less than 0.1%): Injection site hemorrhage, catheter site hemorrhage, incision site hemorrhage

Editorial References and Review

Medically reviewed by BestRx Medical Team Last updated on 1/1/2020.

Source: Drugs.com Pradaxa